Adia Nutrition Inc. Announces Acquisition of Biolete, Expanding Its Portfolio With Organic Protein and Mushroom Coffee
Adia Nutrition Inc. Announces Acquisition of Biolete, Expanding Its Portfolio With Organic Protein and Mushroom Coffee
Winter Park, Florida--(Newsfile Corp. - July 23, 2024) - ADIA Nutrition Inc. (OTC Pink: ADIA), an innovative provider of nutritional supplements, is pleased to announce the acquisition of Biolete LLC, a pioneering company in the development of protein coffee with mushrooms. This strategic move marks a significant milestone for ADIA Nutrition as it continues to expand its portfolio and provide original solutions to meet the evolving needs of its customers.
佛羅里達州溫特帕克——(新聞稿前披露-2024年7月23日)-ADIA營養品公司(OTC粉紅股票代碼:ADIA)是一家創新的營養補充劑供應商,很高興宣佈收購Biolete LLC,這是一家在蛋白質咖啡和蘑菇開發方面開創性的公司。這一戰略舉措標誌着ADIA營養的一個重要里程碑,因爲它繼續擴大其投資組合,並提供原始解決方案,以滿足其客戶不斷髮展的需求。
Protein coffees and mushroom extracts have recently gained considerable attention for their potential health benefits, including increased energy, improved focus, and enhanced immune support. Biolete prides itself for its US manufactured coffee with organic ingredients of collagen protein and mushrooms which gives the energy-boosting benefits of coffee without the negative side effects. By acquiring 100% of Biolete, including its trademarks, inventory, customer base, and website, ADIA Nutrition is poised to strengthen its position in the rapidly growing functional beverage market.
蛋白咖啡和蘑菇提取物因其對健康的潛在益處(包括增加能量、提高注意力和增強免疫支持能力)而近來備受矚目。Biolete以含有膠原蛋白和蘑菇有機成分的美國製造咖啡自詡可以提供增強能量的好處,而不會帶來負面副作用。 ADIA Nutrition通過收購Biolete的100%股權,包括其商標、庫存、客戶群和網站,以提高在快速增長的功能性飲料市場上的立場。
"We are thrilled to welcome Biolete to the ADIA family," said Larry Powalisz, CEO of ADIA Nutrition Inc. "Biolete's innovative approach to combining the benefits of protein and mushrooms in a delicious coffee beverage aligns perfectly with our mission to revolutionize the supplement industry and empower individuals to prioritize their health and well-being. We are excited to leverage our combined resources and expertise to bring Biolete's exceptional product to a wider audience."
「我們非常高興歡迎Biolete加入ADIA大家庭,」ADIA營養公司CEO拉里·波瓦里茲表示。 「Biolete在蛋白質和蘑菇結合成美味的咖啡飲料的創新方法與我們革命營養品行業和賦予個人優先考慮健康和福祉的使命完美契合。我們很興奮利用我們的綜合資源和專業知識,把Biolete傑出的產品帶給更廣泛的觀衆。」
Biolete accepted ADIA's equity offer of preferred shares that are regulated under Rule 144 (which does not affect the current outstanding shares of the company). This acquisition is a testament to ADIA's commitment to expanding its product offerings and delivering value to their shareholders.
Biolete接受了ADIA的優先股權報價,這些股票受144條規管制(不影響公司當前的流通股)。這項收購證明了ADIA擴大產品系列和爲股東創造價值的承諾。
Kevin Masson, founder of Biolete, expressed his enthusiasm for the acquisition, stating, "I am excited to have sold Biolete to ADIA Nutrition as an equity investment. I believe that ADIA Nutrition is the perfect partner to help take Biolete to the next level and continue to provide our customers with the highest quality products."
Biolete創始人凱文·馬松(Kevin Masson)對收購表示熱情洋溢,稱「我很興奮把Biolete作爲股權投資出售給ADIA營養。我相信ADIA營養是幫助Biolete走向更高水平的完美夥伴,並繼續向我們的客戶提供最高質量產品。」
The acquisition of Biolete is expected to immediately attribute to ADIA Nutrition's earnings and will provide new opportunities for growth and expansion. The company plans to integrate Biolete's operations seamlessly and add additional distribution channels to accelerate the adoption of its protein and mushroom coffee.
收購Biolete預計會立即對ADIA Nutrition的收益產生貢獻,併爲增長和擴張提供新機遇。該公司計劃無縫整合Biolete的運營,並增加額外的分銷渠道,以加速蛋白質和蘑菇咖啡的推廣。
For media inquiries or further information, please contact Larry Powalisz at ceo@adiamed.com or 321-788-0850.
有關媒體查詢或更多信息,請通過ceo@adiamed.com或321-788-0850聯繫Larry Powalisz。
Biolete.com
Biolete.com
adianutrition.com or X (Twitter) "adia_nutrition"
adianutrition.com或 X (Twitter) "adia_nutrition"
About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division specializing in Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments for Multiple Sclerosis (MS). Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
關於ADIA營養公司:
Adia營養公司是一家公開交易公司(OTC Pink:ADIA),致力於改革醫療保健和補充劑。公司專注於創新和質量,已建立了兩個關鍵部門:提供高質量有機補充劑的補充部門和專門從事多發性硬化症(MS)的自體造血幹細胞移植(aHSCT)治療的醫療部門。通過這些部門,Adia營養公司致力於通過滿足營養需求和突破性的醫療治療措施來賦予個人更好的生活。
Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.
安全港:本新聞稿包含根據1933年證券法第27A條和1934年證券交易法第21E條的前瞻性聲明。這些前瞻性聲明基於管理層的當前計劃和期望,並受到一些不確定性和風險的影響,這些風險和不確定性可能會顯著影響公司的當前計劃和期望,以及未來的經營業績和財務狀況。關於公司業務前景以及可能影響公司業務前景並導致實際結果與前瞻性聲明描述的結果有很大不同的風險和因素的更詳細列表,可以在公司向證券交易委員會和OTC Markets,Inc. OTC Disclosure and News Service提交的報告和其他文件中找到。公司不承擔公開更新或修訂任何前瞻性聲明的義務,因爲有新信息,未來事件或其他情況。